A new product in aesthetic medicine technologies has been launched in the Turkish market

A new product in aesthetic medicine technologies has been launched in the Turkish market

A new generation of technology focusing on cellular regeneration in the fields of aesthetic medicine and dermatology has been launched in Turkey. Developed by Italy-based Telea Medical and based on QMR (Quantum Molecular Resonance) technology, Rexonage 3 has taken its place in the Turkish market through BeautyForm Medical. BeautyForm Medical General Manager Erol Gürsoy said, "We believe that this technology will advance both treatment results and patient experience."

The system, which operates with high-frequency biophysical energy, aims to activate cell metabolism and initiate the natural regeneration process in tissues. Rexonage 3 differs from traditional applications such as radiofrequency and laser in that it operates without generating thermal effects.

A BIOPHYSICAL METHOD THAT DOES NOT GENERATE HEAT

The system, which aims to influence cellular metabolism and support regeneration processes in tissues using high-frequency biophysical energy, incorporates a technology that operates without generating thermal effects. Stating that this aspect distinguishes it from some heat-based aesthetic applications, BeautyForm Medical General Manager Erol Gürsoy said, “In aesthetic medicine, not only visible results but also biologically sustainable improvements are now at the forefront. With Rexonage 3, we are bringing an approach that works at the cellular level and activates the tissue's own regeneration mechanism to physicians in Turkey. We believe that this technology will advance both treatment results and patient experience.”

GROWTH CONTINUES IN THE NON-INVASIVE TREATMENT MARKET

"Non-invasive" in the literature refers to treatments that support the treatment process with externally applied technologies without disrupting body integrity, without the need to cut the skin or insert instruments into body cavities. Gürsoy stated that the technology was brought to Turkey through a partnership with the Italian company Telea Medical, which manufactures within the framework of European Union Health Programs, and added, "Rexonage 3 has a wide range of applications, including skin rejuvenation, wrinkle reduction, acne and skin sensitivities, hair treatments, and post-surgical recovery processes. Thanks to its non-invasive nature, it offers patients a painless and comfortable experience. The fact that it doesn't require a recovery period after the procedure is also among its important advantages. Furthermore, its ability to be combined with applications such as PRP (injectable regeneration) and laser treatments increases treatment effectiveness." Supported by scientific studies, QMR technology is considered a harbinger of a new era in aesthetic medicine with its approach targeting cellular-level regeneration.

CLINICAL FINDINGS POINT TO INCREASED COLLAGEN PRODUCTION, SCIENTIFIC STUDIES CONTINUE

According to Italian giant Telea Medical, some published clinical studies on QMR technology report an increase in collagen production and tissue quality parameters in the dermal layer after application. Studies conducted by the company in various clinical centers in Italy, as well as research carried out in collaborations with university hospitals, have reported measurable changes in indicators such as skin elasticity and dermal density. Telea, based in Vicenza, Italy, also states that observational studies on the effects of regulating inflammation processes and supporting tissue healing are also present in the literature.